Los Angeles Biotech Trending News

Amgen Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK 101 Study In Patients With KRAS G12C-mutated Cancers At AACR-NCI-EORTC 2021

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Oct. 7, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced new combination study results from the Phase 1b CodeBreaK 101 study, a comprehensive global master protocol trial evaluating the […]

Boston Cambridge Biotech Trending News

Phio Pharmaceuticals Presents New BRD4 Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

MARLBOROUGH, Mass.: MARLBOROUGH, Mass., Oct. 7, 2021 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, today presented […]

No Picture
Los Angeles Biotech Trending News

Bristol Myers’ TYK2 drug bombs ulcerative colitis test, but hopes are still high with psoriasis filing on deck

Bristol Myers Squibb’s deucravacitinib, seeking to become the first TYK2 drug approved, flopped a key Phase II test in ulcerative colitis, failing to spur clinical remission at three months and missing key secondary endpoints at […]


Charting Shots

Many medical advances lay at least partial claim to greatest of all time, from older achievements like anesthesia (1846) and antibiotics (1928) to more modern triumphs like organ transplants (1954), stem cell therapy (1970s) and […]